Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride
HealthData.Gov
Updated Jun 12, 2026
About this dataset
This prescription medication combines bismuth subcitrate potassium (140 mg), metronidazole (125 mg), and tetracycline hydrochloride (125 mg) in oral capsules. It's used to treat infections caused by Helicobacter pylori bacteria, often in combination with other therapies for stomach ulcers or gastritis. Take as directed by a doctor. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride
Access the FDA dataset for Bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride โ ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025